Intuitive Surgical (ISRG) Stock Forecast, Price Target & Predictions
ISRG Stock Forecast
Intuitive Surgical stock forecast is as follows: an average price target of $393.85 (represents a -16.53% downside from ISRG’s last price of $471.82) and a rating consensus of 'Buy', based on 17 wall street analysts offering a 1-year stock forecast.
ISRG Price Target
The average price target for Intuitive Surgical (ISRG) is $393.85 based on 1-year price targets from 17 Wall Street analysts in the past 3 months, with a price target range of $560.00 to $280.00. This represents a potential -16.53% downside from ISRG's last price of $471.82.
ISRG Analyst Ratings
According to 17 Wall Street analysts, Intuitive Surgical's rating consensus is 'Buy'. The analyst rating breakdown for ISRG stock is 0 'Strong Buy' (0.00%), 13 'Buy' (76.47%), 4 'Hold' (23.53%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Intuitive Surgical Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 22, 2024 | Joanne Wuensch | Citigroup | $560.00 | $487.42 | 14.89% | 18.69% |
| Jul 19, 2024 | Drew Ranieri | Morgan Stanley | $475.00 | $451.61 | 5.18% | 0.67% |
| Jul 19, 2024 | Vijay Kumar | Evercore ISI | $410.00 | $416.14 | -1.48% | -13.10% |
| Jul 19, 2024 | Rick Wise | Stifel Nicolaus | $475.00 | $416.14 | 14.14% | 0.67% |
| Jul 19, 2024 | Richard Newitter | Truist Financial | $520.00 | $455.01 | 14.28% | 10.21% |
| Jul 19, 2024 | Adam Maeder | Piper Sandler | $495.00 | $416.14 | 18.95% | 4.91% |
| Jul 16, 2024 | Richard Newitter | Truist Financial | $515.00 | $440.64 | 16.87% | 9.15% |
| May 30, 2024 | David Roman | Goldman Sachs | $500.00 | $398.40 | 25.50% | 5.97% |
| Apr 19, 2024 | Adam Maeder | Piper Sandler | $435.00 | $368.17 | 18.15% | -7.80% |
| Apr 19, 2024 | Matthew Taylor | Jefferies | $375.00 | $372.63 | 0.64% | -20.52% |
The latest Intuitive Surgical stock forecast, released on Aug 22, 2024 by Joanne Wuensch from Citigroup, set a price target of $560.00, which represents a 14.89% increase from the stock price at the time of the forecast ($487.42), and a 18.69% increase from ISRG last price ($471.82).
Intuitive Surgical Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 7 | 17 |
| Avg Price Target | $560.00 | $492.86 | $436.59 |
| Last Closing Price | $471.82 | $471.82 | $471.82 |
| Upside/Downside | 18.69% | 4.46% | -7.47% |
In the current month, the average price target of Intuitive Surgical stock is $560.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 18.69% increase as opposed to Intuitive Surgical's last price of $471.82. This month's average price target is up 13.62% compared to last quarter, and up 28.27% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 28, 2024 | BTIG | Buy | Buy | Hold |
| Aug 22, 2024 | Citigroup | Buy | Buy | Hold |
| Aug 16, 2024 | RBC Capital | Outperform | Outperform | Hold |
| Jul 19, 2024 | William Blair | Outperform | Outperform | Hold |
| Jul 19, 2024 | Evercore ISI | Positive | Positive | Hold |
| Jul 19, 2024 | BTIG | Buy | Buy | Hold |
| Jul 18, 2024 | Barclays | Overweight | Overweight | Hold |
| Jul 15, 2024 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
| Jul 10, 2024 | Citigroup | Buy | Buy | Hold |
| Jul 09, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Intuitive Surgical's last stock rating was published by BTIG on Aug 28, 2024. The company gave ISRG a "Buy" rating, the same as its previous rate.
Intuitive Surgical Financial Forecast
Intuitive Surgical Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $1.93B | $1.74B | $1.76B | $1.70B | $1.66B | $1.56B | $1.52B | $1.49B | $1.55B | $1.40B | $1.46B | $1.29B | $1.33B | $1.08B | $852.10M | $1.10B | $1.28B | $1.13B |
| Avg Forecast | $2.85B | $2.61B | $2.62B | $2.47B | $2.54B | $2.33B | $2.32B | $2.18B | $2.18B | $2.01B | $1.97B | $1.87B | $1.89B | $1.77B | $1.74B | $1.59B | $1.67B | $1.56B | $1.56B | $1.43B | $1.52B | $1.38B | $1.27B | $1.11B | $1.25B | $970.98M | $671.39M | $1.05B | $1.23B | $1.07B |
| High Forecast | $2.90B | $2.66B | $2.67B | $2.51B | $2.58B | $2.37B | $2.36B | $2.22B | $2.22B | $2.04B | $2.01B | $1.90B | $1.92B | $1.80B | $1.77B | $1.62B | $1.70B | $1.59B | $1.59B | $1.45B | $1.55B | $1.41B | $1.29B | $1.13B | $1.27B | $986.71M | $682.27M | $1.06B | $1.25B | $1.08B |
| Low Forecast | $2.74B | $2.51B | $2.52B | $2.37B | $2.44B | $2.24B | $2.23B | $2.09B | $2.09B | $1.97B | $1.89B | $1.80B | $1.81B | $1.70B | $1.67B | $1.53B | $1.60B | $1.50B | $1.51B | $1.38B | $1.48B | $1.34B | $1.23B | $1.08B | $1.21B | $942.45M | $651.66M | $1.01B | $1.19B | $1.04B |
| # Analysts | 8 | 8 | 12 | 8 | 12 | 7 | 7 | 13 | 9 | 17 | 8 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 9 | 9 | 9 | 9 | 5 | 5 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 0.99% | 1.01% | 1.06% | 0.99% | 1.00% | 0.98% | 1.04% | 1.02% | 1.01% | 1.15% | 1.16% | 1.06% | 1.11% | 1.27% | 1.05% | 1.04% | 1.06% |
Intuitive Surgical's average Quarter revenue forecast for Mar 24 based on 10 analysts is $1.87B, with a low forecast of $1.80B, and a high forecast of $1.90B. ISRG's average Quarter revenue forecast represents a -3.01% decrease compared to the company's last Quarter revenue of $1.93B (Dec 23).
Intuitive Surgical EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 8 | 8 | 12 | 8 | 12 | 7 | 7 | 13 | 9 | 17 | 8 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 9 | 9 | 9 | 9 | 5 | 5 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $573.40M | $465.80M | $463.20M | $387.60M | $372.50M | $398.90M | $397.60M | $408.10M | $533.00M | $536.40M | $596.00M | $511.60M | $517.90M | $421.50M | $168.80M | $368.80M | $490.50M | $448.00M |
| Avg Forecast | $813.93M | $745.51M | $748.58M | $704.13M | $723.79M | $666.06M | $662.70M | $621.93M | $622.14M | $572.49M | $562.84M | $550.10M | $539.03M | $505.25M | $497.14M | $500.09M | $476.69M | $584.31M | $445.49M | $454.63M | $434.36M | $395.23M | $361.85M | $338.47M | $356.61M | $277.19M | $191.66M | $347.02M | $351.46M | $304.41M |
| High Forecast | $828.23M | $758.61M | $761.73M | $716.50M | $736.51M | $677.76M | $674.35M | $632.86M | $633.08M | $581.00M | $572.72M | $660.12M | $548.50M | $514.13M | $505.87M | $600.11M | $485.06M | $701.17M | $452.71M | $545.56M | $441.40M | $401.63M | $367.72M | $406.17M | $362.39M | $281.68M | $194.77M | $416.42M | $357.16M | $309.35M |
| Low Forecast | $782.15M | $716.40M | $719.34M | $676.63M | $695.53M | $640.05M | $636.83M | $597.65M | $597.85M | $561.16M | $540.86M | $440.08M | $517.98M | $485.52M | $477.73M | $400.07M | $458.07M | $467.45M | $432.40M | $363.70M | $421.60M | $383.62M | $351.22M | $270.78M | $346.14M | $269.04M | $186.03M | $277.62M | $341.13M | $295.47M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.06% | 0.92% | 0.93% | 0.78% | 0.78% | 0.68% | 0.89% | 0.90% | 1.23% | 1.36% | 1.65% | 1.51% | 1.45% | 1.52% | 0.88% | 1.06% | 1.40% | 1.47% |
10 analysts predict ISRG's average Quarter EBITDA for Mar 24 to be $550.10M, with a high of $660.12M and a low of $440.08M. This is -4.06% lower than Intuitive Surgical's previous annual EBITDA (Dec 23) of $573.40M.
Intuitive Surgical Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 8 | 8 | 12 | 8 | 12 | 7 | 7 | 13 | 9 | 17 | 8 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 9 | 9 | 9 | 9 | 5 | 5 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $606.20M | $415.70M | $420.80M | $355.30M | $324.90M | $324.00M | $307.80M | $365.60M | $382.70M | $380.50M | $517.20M | $426.30M | $365.20M | $313.90M | $68.00M | $313.50M | $357.70M | $396.80M |
| Avg Forecast | $842.27M | $788.60M | $795.65M | $718.00M | $731.05M | $700.39M | $700.20M | $632.63M | $619.50M | $592.54M | $556.61M | $421.90M | $535.71M | $511.06M | $479.89M | $383.54M | $451.63M | $414.49M | $432.19M | $348.67M | $461.55M | $420.77M | $369.95M | $282.04M | $375.99M | $247.94M | $64.12M | $294.99M | $406.44M | $359.88M |
| High Forecast | $861.50M | $806.62M | $813.82M | $734.40M | $747.75M | $716.38M | $716.20M | $647.08M | $633.66M | $617.67M | $569.32M | $506.27M | $557.57M | $522.74M | $490.85M | $460.25M | $461.95M | $497.38M | $441.30M | $418.41M | $471.27M | $429.63M | $377.74M | $338.45M | $383.91M | $253.16M | $65.47M | $353.98M | $415.00M | $367.47M |
| Low Forecast | $799.51M | $748.57M | $755.26M | $681.56M | $693.94M | $664.83M | $664.66M | $600.51M | $588.06M | $567.40M | $528.35M | $337.52M | $510.20M | $485.12M | $455.53M | $306.83M | $428.71M | $331.59M | $415.68M | $278.94M | $443.93M | $404.70M | $355.82M | $225.63M | $361.63M | $238.47M | $61.68M | $235.99M | $390.91M | $346.14M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.13% | 0.81% | 0.88% | 0.93% | 0.72% | 0.78% | 0.71% | 1.05% | 0.83% | 0.90% | 1.40% | 1.51% | 0.97% | 1.27% | 1.06% | 1.06% | 0.88% | 1.10% |
Intuitive Surgical's average Quarter net income forecast for Mar 24 is $421.90M, with a range of $337.52M to $506.27M. ISRG's average Quarter net income forecast represents a -30.40% decrease compared to the company's last Quarter net income of $606.20M (Dec 23).
Intuitive Surgical SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 8 | 8 | 12 | 8 | 12 | 7 | 7 | 13 | 9 | 17 | 8 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 9 | 9 | 9 | 9 | 5 | 5 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $567.10M | $452.00M | $464.30M | $480.50M | $494.30M | $436.10M | $418.40M | $391.10M | $427.00M | $363.30M | $350.20M | $326.00M | $330.20M | $298.90M | $279.10M | $308.10M | $341.80M | $284.00M |
| Avg Forecast | $772.28M | $707.36M | $710.27M | $668.09M | $686.75M | $631.97M | $628.79M | $590.11M | $590.31M | $543.20M | $534.03M | $451.32M | $511.44M | $479.39M | $471.70M | $410.29M | $452.29M | $395.75M | $422.69M | $372.99M | $412.13M | $375.00M | $343.34M | $215.68M | $338.37M | $263.00M | $181.85M | $289.91M | $333.47M | $288.84M |
| High Forecast | $785.85M | $719.79M | $722.75M | $679.83M | $698.82M | $643.08M | $639.84M | $600.47M | $600.68M | $551.27M | $543.42M | $541.59M | $520.43M | $487.82M | $479.98M | $492.35M | $460.24M | $474.90M | $429.54M | $447.59M | $418.81M | $381.08M | $348.90M | $258.82M | $343.85M | $267.26M | $184.80M | $347.89M | $338.88M | $293.52M |
| Low Forecast | $742.13M | $679.74M | $682.53M | $642.01M | $659.94M | $607.30M | $604.24M | $567.06M | $567.26M | $532.44M | $513.18M | $361.06M | $491.47M | $460.68M | $453.28M | $328.23M | $434.63M | $316.60M | $410.27M | $298.39M | $400.02M | $363.99M | $333.25M | $172.54M | $328.42M | $255.28M | $176.51M | $231.92M | $323.68M | $280.35M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.11% | 0.94% | 0.98% | 1.17% | 1.09% | 1.10% | 0.99% | 1.05% | 1.04% | 0.97% | 1.02% | 1.51% | 0.98% | 1.14% | 1.53% | 1.06% | 1.02% | 0.98% |
Intuitive Surgical's average Quarter SG&A projection for Mar 24 is $451.32M, based on 10 Wall Street analysts, with a range of $361.06M to $541.59M. The forecast indicates a -20.42% fall compared to ISRG last annual SG&A of $567.10M (Dec 23).
Intuitive Surgical EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 8 | 8 | 12 | 8 | 12 | 7 | 7 | 13 | 9 | 17 | 8 | 10 | 11 | 5 | 5 | 9 | 5 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 9 | 9 | 9 | 9 | 5 | 5 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.18 | $1.20 | $1.01 | $0.93 | $0.91 | $0.86 | $1.02 | $1.07 | $1.07 | $1.45 | $1.20 | $1.04 | $0.89 | $0.19 | $0.90 | $1.03 | $1.15 |
| Avg Forecast | $2.33 | $2.18 | $2.20 | $1.99 | $2.03 | $1.94 | $1.94 | $1.75 | $1.72 | $1.64 | $1.54 | $1.42 | $1.48 | $1.42 | $1.33 | $1.20 | $1.25 | $1.20 | $1.20 | $1.08 | $1.28 | $1.17 | $1.02 | $0.88 | $1.04 | $0.69 | $0.18 | $0.88 | $1.13 | $1.00 |
| High Forecast | $2.39 | $2.23 | $2.25 | $2.03 | $2.07 | $1.98 | $1.98 | $1.79 | $1.76 | $1.71 | $1.58 | $1.45 | $1.54 | $1.45 | $1.36 | $1.22 | $1.28 | $1.22 | $1.22 | $1.10 | $1.31 | $1.19 | $1.05 | $0.90 | $1.06 | $0.70 | $0.18 | $0.90 | $1.15 | $1.02 |
| Low Forecast | $2.21 | $2.07 | $2.09 | $1.89 | $1.92 | $1.84 | $1.84 | $1.66 | $1.63 | $1.57 | $1.46 | $1.34 | $1.41 | $1.34 | $1.26 | $1.14 | $1.19 | $1.14 | $1.15 | $1.04 | $1.23 | $1.12 | $0.99 | $0.85 | $1.00 | $0.66 | $0.17 | $0.85 | $1.08 | $0.96 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.83% | 0.90% | 0.84% | 0.74% | 0.76% | 0.72% | 0.95% | 0.84% | 0.92% | 1.42% | 1.36% | 1.00% | 1.30% | 1.09% | 1.02% | 0.91% | 1.15% |
According to 11 Wall Street analysts, Intuitive Surgical's projected average Quarter EPS for Dec 23 is $1.48, with a low estimate of $1.41 and a high estimate of $1.54. This represents a 25.76% increase compared to ISRG previous annual EPS of $1.18 (Sep 23).
Intuitive Surgical Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| BNGO | Bionano Genomics | $0.44 | $59.33 | 13384.09% | Buy |
| COO | Cooper Companies | $106.59 | $298.00 | 179.58% | Buy |
| BAX | Baxter | $38.96 | $64.62 | 65.86% | Hold |
| RGEN | Repligen | $147.07 | $189.50 | 28.85% | Buy |
| TFX | Teleflex | $244.53 | $304.09 | 24.36% | Buy |
| BDX | Becton, Dickinson and Company | $232.67 | $280.55 | 20.58% | Buy |
| WST | West Pharmaceutical Services | $297.24 | $345.33 | 16.18% | Buy |
| HOLX | Hologic | $81.57 | $78.92 | -3.25% | Buy |
| MMSI | Merit Medical Systems | $96.58 | $92.13 | -4.61% | Buy |
| RMD | ResMed | $244.87 | $209.33 | -14.51% | Hold |
| ISRG | Intuitive Surgical | $471.82 | $393.85 | -16.53% | Buy |
| ICUI | ICU Medical | $162.32 | $135.00 | -16.83% | Buy |
| EMBC | Embecta | $15.31 | $12.00 | -21.62% | Sell |
ISRG Forecast FAQ
Is Intuitive Surgical a good buy?
Yes, according to 17 Wall Street analysts, Intuitive Surgical (ISRG) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 13 'Buy' recommendations, accounting for 76.47% of ISRG's total ratings.
What is ISRG's price target?
Intuitive Surgical (ISRG) average price target is $393.85 with a range of $280 to $560, implying a -16.53% from its last price of $471.82. The data is based on 17 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Intuitive Surgical stock go up soon?
According to Wall Street analysts' prediction for ISRG stock, the company can go down by -16.53% (from the last price of $471.82 to the average price target of $393.85), up by 18.69% based on the highest stock price target, and down by -40.66% based on the lowest stock price target.
Can Intuitive Surgical stock reach $700?
ISRG's average twelve months analyst stock price target of $393.85 does not support the claim that Intuitive Surgical can reach $700 in the near future.
What is Intuitive Surgical's current price target trend?
1 Wall Street analyst forecast a $560 price target for Intuitive Surgical (ISRG) this month, up 18.69% from its last price of $471.82. Compared to the last 3 and 12 months, the average price target increased by 4.46% and decreased by -7.47%, respectively.
What are Intuitive Surgical's analysts' financial forecasts?
Intuitive Surgical's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $9.37B (high $9.53B, low $9B), average EBITDA is $2.67B (high $2.72B, low $2.57B), average net income is $2.76B (high $2.83B, low $2.62B), average SG&A $2.54B (high $2.58B, low $2.44B), and average EPS is $7.66 (high $7.83, low $7.27). ISRG's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $10.55B (high $10.74B, low $10.14B), average EBITDA is $3.01B (high $3.07B, low $2.89B), average net income is $3.14B (high $3.22B, low $2.98B), average SG&A $2.86B (high $2.91B, low $2.75B), and average EPS is $8.71 (high $8.91, low $8.27).
Did the ISRG's actual financial results beat the analysts' financial forecasts?
Based on Intuitive Surgical's last annual report (Dec 2023), the company's revenue was $7.12B, beating the average analysts forecast of $6.99B by 1.88%. Apple's EBITDA was $2.19B, beating the average prediction of $2.04B by 7.20%. The company's net income was $1.8B, missing the average estimation of $1.91B by -5.87%. Apple's SG&A was $1.96B, beating the average forecast of $1.87B by 4.86%. Lastly, the company's EPS was $5.12, missing the average prediction of $5.43 by -5.63%. In terms of the last quarterly report (Dec 2023), Intuitive Surgical's revenue was $1.93B, beating the average analysts' forecast of $1.89B by 2.12%. The company's EBITDA was $573.4M, beating the average prediction of $539.03M by 6.38%. Intuitive Surgical's net income was $606.2M, beating the average estimation of $535.71M by 13.16%. The company's SG&A was $567.1M, beating the average forecast of $511.44M by 10.88%. Lastly, the company's EPS was $0, missing the average prediction of $1.48 by -100.00%